OpenAlex
PricingAboutJobs
Log inGet started
Work

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

HTML

Year: 2015
Type: article
Source: Tumor Biology
DOI: 10.1007/s13277-015-4523-7
Authors: Ondrej Fiala, Tomas Buchler, Beatrice Mohelnikova-Duchonova, Bohuslav Melichar, Vit Martin Matejka, Lubos Holubec, Jana Kulhankova, Zbynek Bortlicek, Marie Bartouskova, Vaclav Liska, Ondrej Topolcan, Monika Sedivcova, Jindrich Finek
Institutions: Charles University, Thomayer University Hospital, Palacký University Olomouc, Masaryk University, Biopticka Laborator (Czechia)
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: KRAS mutation, metastatic colorectal cancer, bevacizumab, prognostic factors, progression-free survival, overall survival, Ras signaling, angiogenesis
SDG: Good health and well-being

Open Access status: closed

Funder: Ministerstvo Školství, Mládeže a Tělovýchovy
OpenAlex ID: W2464728687
FWCI: 1.19
Cites: 43
Cited by: 59
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security